Tambagel, Jenny Grace .

HRN: 20-23-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2022
CEFUROXIME 750MG (VIAL)
05/19/2022
05/22/2022
IV
750mg
Q8
G1P1 PROM 46h

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines